Jeff R. Livingstone, PhD., is the Vice President for the Unisys Enterprise Solutions division and leads the Life Sciences and Healthcare industry worldwide. He brings over 30 years’ experience leading large-scale change programs with global teams. His rare combination of knowledge about the science of drug discovery and molecular engineering, and deep cybersecurity and IT background, provide the necessary perspective to create highly impactful LSH solutions yielding clear, measurable results. Jeff has held numerous roles during his multi-faceted career across sales, marketing, product and service development, program management, business development and corporate management. Jeff has a PhD, Physical Biochemistry from the University of Wisconsin-Madison and a BS in Biochemistry from the University of Missouri-Columbia. He performed post-graduate work on new AIDS therapies at the NIH / Frederick Cancer Research Center and was part of a small team at Genentech responsible for creating the first anti-Her2 humanized antibody biotherapetic (Herceptin™). He is a specialist in physical biochemistry and biophysics and has published several reviewed articles in this area.